Relationship between Mecp2 and NFκb signaling during neural differentiation of P19 cells

Cliona O'Driscoll, Walter E. Kaufmann, Joseph Bressler

Research output: Contribution to journalArticle

Abstract

The pluripotent P19 embryo carcinoma cell line was studied to determine a signaling pathway regulating MeCP2 expression. P19 cells were induced to differentiate into neurons by RA and express β-III tubulin at one day after induction and synaptophysin by 7 days. MeCP2 was first observed after β-III tubulin expression was detected and continued to rise over the course of differentiation. Both Mecp2 e1 and e2 mRNA forms progressively increased in differentiating cells. MeCP2 expression was increased by tumor necrosis factor (TNF) in early differentiating cells, which was blocked by NFκB inhibitors. TNF did not increase MeCP2 expression in naïve cells. Moreover, TNF did not increase NFκB reporter gene activity in naïve cells even though increases were observed in early differentiating cells. The protein kinase C activator phorbol 12-myristate 13-acetate (PMA) increased MeCP2 expression in naïve P19 cells, which was also blocked by NFκB inhibitors. Interestingly, PMA increased NFκB reporter gene activity in naïve cells. Finally, PMA, but not TNF, induced IκBα degradation in naïve P19 cells. Taken together, our data indicates that MeCP2 expression is regulated in part by signaling pathways involving NFκB.

Original languageEnglish (US)
Pages (from-to)35-42
Number of pages8
JournalBrain Research
Volume1490
DOIs
Publication statusPublished - Jan 15 2013

    Fingerprint

Keywords

  • Development
  • Methyl DNA binding protein 2
  • NFκB
  • P19 embryonic carcinoma cells
  • Tumor necrosis factor

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology
  • Developmental Biology
  • Molecular Biology

Cite this